|
|
|
|
| Executive Profile |
|
|
Compliance Disruptors |
Pharm Exec sits down with a pair of big pharma compliance leaders to discuss the strategic move to principles-based policies at their companies and the impact of other emerging forces influencing industry compliance practice, including data analytics and security and training approaches adaptable to a changing workplace dynamic.
... /Read more/ |
|
|
| Advertisement |
Exclusive Interview from eyeforpharma
Knowledge, Data, Trust: Supporting the HCP-Pharma Ecosystem
 Watch Now
Sponsored by: Aptus Health
|
|
|
| Advertisement |
Managing Global Regulatory Complexity: Clinical Trial Transparency, Reporting and Real-time Data Driven Compliance
Wednesday, August 14, 2019 at 12pm EDT | 9am PDT | 5pm BST | 6pm CEST
 Register Now
|
| Q&A |
|
|
The Call to Cure: Geoff MacKay, AVROBIO
|
A pioneer in building businesses and innovation in gene-based medicine, including the first FDA-approved allogeneic cell therapy, Geoff MacKay, CEO of lentiviral-focused developer AVROBIO, discusses his most important quest to date–bringing gene therapy into the mainstream.
... /Read more/ |
|
|
| Differentiating Yourself in Crowded Therapeutic Areas |
 |
|
The Pharm Exec Podcast: Episode 37 |
Pharm Exec editors sit down with Mark Velleca, CEO of G1 Therapeutics. In this episode, Mark talks about how he differentiates himself in the oncology field, why he considers G1 Therapeutics an "old school company," and about the North Carolina biotech landscape.
... /Read more/ |
| |
|
|
|
|
|
|
